The GCC Grand Tours Visa, due in 2026 with a possible late-2025 pilot, will let travelers use one digital permit…
In late 2025 the U.S. broadened health-related public charge reviews for immigrant visas, weighing chronic conditions and applicants’ ability to…
For medical B-2 visas, applicants must provide two matching medical letters, realistic cost estimates, and verifiable funds that align with…
New guidance tells consular officers to weigh contagiousness and likely medical costs when reviewing B1/B2 visas, without adding medical exams.…
2025 guidance keeps a narrow CDC disease list for visa refusals and stresses treatment-first outcomes. New scrutiny examines whether chronic…
Social posts falsely claimed diabetes disqualifies visa applicants. In reality, immigrant exams screen infectious diseases; chronic illnesses may factor into…
Controlled high blood pressure does not bar B1/B2 visa issuance or extensions when the condition is stable and self‑managed. Consular…
The 2025 India–Singapore DTAA upholds post-2019 rules: most capital gains from Indian shares held by Singapore residents are taxed in…
Sign in to your account